A phase II study of irinotecan, high-dose 24-h continuous intravenous infusion of floxuridine and leucovorin (IFLUX) for advanced, previously untreated colorectal cancer

Bach Ardalan, Olga Kozyreva, Kao Tai Tsai, Edgardo Santos, Dido Franceschi, Alan Livingstone, Mayra Lima

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of irinotecan, high-dose 24-h continuous intravenous infusion of floxuridine and leucovorin (IFLUX) for advanced, previously untreated colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences